시장보고서

상품코드

1455673

리프트 밸리 열 백신 시장 : 제품 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Rift Valley Fever Vaccines Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 03월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

리프트밸리 열백신 시장 규모는 2023년에 2억 1,045만 달러로 평가되었고, 2024년부터 2032년까지 CAGR 6.2%로 확대될 것으로 예측되고 있습니다.

리프트 밸리 열 백신 시장-시장 역학

공중위생 교육과 사회 및 의료 환경의 진보에 의한 인지도의 향상이 시장 수요를 촉진

리프트 밸리 열 백신 시장은 공중위생 교육에 의한 의식의 고조와 사회 및 의료 환경의 진보에 의해 큰 성장을 이루고 있습니다. 기술의 진보로 의료 및 동물 전문가가 인간과 동물 모두에 효율적으로 백신을 접종할 수 있게 되어 시장 확대를 더욱 촉진하고 있습니다. 리프트 밸리 열 백신의 촉진요인으로는 특히 유행지역에서 리프트 밸리 열의 유행이 증가하고 있어 효과적인 예방대책의 긴급성이 높아지고 있는 것을 들 수 있습니다. 또한, 리프트 밸리 열의 경제적, 공중보건적 영향에 대한 정부, 의료기관, 농업 부문의 의식 증가는 질병 관리에 대한 적극적인 접근법으로서 예방접종의 중요성을 강조합니다. 또한, 백신 기술과 연구의 진보는 업계 이해관계자와 규제기관의 협력적인 노력과 함께 리프트 밸리 열 백신의 개발과 입수의 용이성에 기여하고 있습니다. 이러한 요인들은 리프트 밸리 열의 만연을 완화시키고 관련 이환율과 사망률을 감소시키는 데 백신 접종이 매우 중요한 역할을 한다는 것을 강조합니다. 그러나 잠재적인 부반응에 대한 우려는 이러한 긍정적인 요인에도 불구하고 시장 성장을 방해할 수 있습니다.

리프트 밸리 열 백신 시장-주요 인사이트

세계 시장은 예측 기간(2024-2032년)에 약 6.2%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측되고 있습니다.

제품 유형별로 생 백신이 2023년에 가장 큰 시장 점유율을 나타낸 것으로 평가되었습니다.

용도별로는 2023년에는 소가 주요 유형이 되었습니다.

지역별로 북미는 2023년 주요 수익원이 되었습니다.

리프트 밸리 열 백신 시장-세분화 분석 :

세계의 리프트 밸리 열 백신 시장은 제품 유형별, 용도별 및 지역별에 따라 세분화됩니다.

시장은 제품 유형에 따라 불활성화 백신과 생백신의 두 가지 범주로 나뉩니다. 리프트 밸리 열 백신 시장에서 생 백신은 견고하고 지속적인 면역 반응을 일으킬 수 있으므로 제품 유형별로 생 백신이 우세합니다. 이 백신은 리프트 밸리 열 바이러스의 약독화 또는 약독화 버전을 포함하며 질병을 유발하지 않고 자연 감염을 반영합니다. 이로 인해 왕성한 면역 반응이 일어나 항체와 기억 세포가 생성되어 향후 감염에 대한 방어가 가능해집니다. 생백신은 그 효과와 다양한 동물종이나 개체군에 폭넓은 면역을 줄 가능성이 평가되어 리프트 밸리 열의 백신접종에 바람직한 선택이 되고 있습니다.

시장은 용도별로 소, 염소, 사람, 양 및 기타 5가지 범주로 나뉩니다. 용도별로 2023년에는 암소 분야가 시장의 지배적인 부문으로 부상했습니다. 소는 리프트 밸리 열 바이러스 감염에 매우 취약하며 가축들 사이에서 발생하면 농부와 농업 부문에 큰 경제적 영향을 미칠 수 있습니다. 리프트 밸리 열에 대한 암소 예방 접종은 질병의 확산을 방지하고 이환율과 사망률을 낮추고 농부의 삶을 보호하는 데 도움이 됩니다. 또한, 암소를 리프트 밸리 열로부터 보호하는 것은 식량 안보를 유지하고 인간 짐승 공통 감염의 인간 감염을 피하기 위해 매우 중요하며,이 중요한 동물 집단을 대상으로 한 백신 접종 노력의 중요성을 강조합니다.

리프트 밸리 열 백신 시장-지리적 인사이트

지리적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다.

리프트 밸리 열 백신 시장-경쟁 구도 :

리프트 밸리 열 백신 시장에서 기업은 효과적이고 사용하기 쉬운 백신 개발을 추진하기 위해 다양한 전략을 실시했습니다. 이러한 전략은 백신 제형의 개선, 투여 요법의 개선, 백신의 안정성 향상 등 특히 자원이 부족한 환경에서의 보관 및 운송을 용이하게 하는 지속적인 연구를 포함합니다. 또한 기업은 백신 개발, 규제 당국의 승인, 유통 과정을 간소화하기 위해 정부, 국제기구, 연구기관과의 협력을 추진하고 있습니다. 또한, 리프트 밸리 열의 발생을 억제하고 동물과 인간의 건강을 지키기 위한 백신접종의 중요성에 대해서, 농가, 수의사, 헬스케어 종사자의 의식을 높이기 위한 교육 캠페인도 실시되고 있습니다.

서문
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 : 리프트 밸리 열 백신 업계

경쟁 대시보드
기업 프로파일
- Veterinary Serum and Vaccine Research Institute
- Medgene Labs
- VSVRI
- Onderstepoort Biological Products
- OBP
- Others

제11장 애널리스트의 전방위 전망

AJY 24.04.09

REPORT HIGHLIGHT

Rift Valley Fever Vaccines Market size was valued at USD 210.45 Million in 2023, expanding at a CAGR of 6.2% from 2024 to 2032.

Rift Valley Fever is a viral illness transmitted through mosquito bites, affecting both humans and animals. The virus spreads through direct contact with infected animal blood and tissues, as well as mosquito bites. While the virus often presents without symptoms, it can lead to serious complications such as encephalitis, blindness, and hemorrhagic fever. Rift Valley Fever vaccines come in two forms: live attenuated RVF vaccine (Smithburn strain) and killed vaccine. Vaccination protects both humans and animals, crucial for food security and economic stability. These vaccines are essential in preventing the spread of this zoonotic disease, playing a significant role in livestock management and public health initiatives, particularly in endemic areas where RVF outbreaks pose substantial risks.

Rift Valley Fever Vaccines Market- Market Dynamics

Increasing awareness through public health education and advancements in social and medical landscapes to propel market demand

The Rift Valley Fever Vaccines Market is experiencing significant growth due to heightened awareness through public health education and advancements in social and medical landscapes. Technological progress enables health and animal professionals to efficiently vaccinate both humans and animals, further driving market expansion. The drivers of Rift Valley Fever vaccines include the increasing prevalence of Rift Valley Fever outbreaks, particularly in endemic regions, which heightens the urgency for effective preventive measures. Additionally, the rising awareness among governments, healthcare organizations, and agricultural sectors about the economic and public health impacts of Rift Valley Fever underscores the importance of vaccination as a proactive approach to disease control. Furthermore, advancements in vaccine technology and research, coupled with collaborative efforts between industry stakeholders and regulatory bodies, contribute to the development and accessibility of Rift Valley Fever vaccines. These drivers collectively emphasize the critical role of vaccination in mitigating the spread of Rift Valley Fever and reducing its associated morbidity and mortality rates. However, concerns regarding potential adverse reactions may impede market growth despite these positive factors.

Rift Valley Fever Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2024-2032)

Based on product type segmentation, Live vaccines was predicted to show maximum market share in the year 2023

Based on Application segmentation, Cattle was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Rift Valley Fever Vaccines Market- Segmentation Analysis:

The Global Rift Valley Fever Vaccines Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on product type: Inactivated and Live. Within the Rift Valley Fever vaccine market, live vaccines take precedence in the type segment due to their capacity to elicit robust and enduring immune responses. These vaccines contain weakened or attenuated versions of the Rift Valley Fever virus, mirroring natural infection without inducing illness. This prompts a vigorous immune reaction, generating antibodies and memory cells that confer protection against future infections. Live vaccines are valued for their efficacy and potential to confer broad immunity across various animal species and populations, making them the preferred option for Rift Valley Fever vaccination initiatives.

The market is divided into five categories based on Application: Cattle, Goats, People, Sheep and Other. Regarding application, in 2023, the cattle segment emerges as the dominant sector in the Rift Valley Fever vaccine market. Cattle are highly vulnerable to Rift Valley Fever virus infection, and outbreaks among livestock can carry significant economic repercussions for farmers and the agricultural sector. Vaccinating cattle against Rift Valley Fever helps prevent disease spread, diminish morbidity and mortality rates, and safeguard farmers' livelihoods. Additionally, shielding cattle from Rift Valley Fever is crucial for upholding food security and averting zoonotic transmission to humans, highlighting the significance of vaccination endeavors targeting this pivotal animal demographic.

Rift Valley Fever Vaccines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rift Valley Fever Vaccines Market- Competitive Landscape:

In the Rift Valley Fever vaccine market, companies are implementing diverse strategies to advance the development of effective and accessible vaccines. These strategies encompass continuous research aimed at enhancing vaccine formulations, refining dosing regimens, and improving vaccine stability to facilitate easier storage and transportation, particularly in resource-constrained environments. Moreover, companies are engaging in collaborations with governments, international organizations, and research institutions to streamline vaccine development, regulatory approval, and distribution processes. Additionally, educational campaigns are being conducted to raise awareness among farmers, veterinarians, and healthcare workers regarding the importance of vaccination in controlling Rift Valley Fever outbreaks and protecting both animal and human health.

Recent Developments:

In April 2023, a significant development was reported: the initiation of a phase 1 clinical trial assessing the safety of a ChAdOx1 vaccine regarding Rift Valley Fever in UK adults. This non-randomized open-label, trial represents a critical milestone in the journey toward combating Rift Valley Fever and underscores the ongoing efforts to develop effective vaccines against this viral illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIFT VALLEY FEVER VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Veterinary Serum and Vaccine Research Institute

Medgene Labs

VSVRI

Onderstepoort Biological Products

OBP

Others

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Inactivated
Live

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cattle
Goats
People
Sheep
Other

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Rift Valley Fever Vaccines Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Rift Valley Fever Vaccines Market Snippet by Product Type
- 2.1.2.Rift Valley Fever Vaccines Market Snippet by Application
- 2.1.3.Rift Valley Fever Vaccines Market Snippet by Country
- 2.1.4.Rift Valley Fever Vaccines Market Snippet by Region
2.2.Competitive Insights

3.Rift Valley Fever Vaccines Key Market Trends

3.1.Rift Valley Fever Vaccines Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Rift Valley Fever Vaccines Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Rift Valley Fever Vaccines Market Opportunities
3.4.Rift Valley Fever Vaccines Market Future Trends

4.Rift Valley Fever Vaccines Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Rift Valley Fever Vaccines Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Rift Valley Fever Vaccines Market Landscape

6.1.Rift Valley Fever Vaccines Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Rift Valley Fever Vaccines Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Inactivated
- 7.1.3.Live

8.Rift Valley Fever Vaccines Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Cattle
- 8.1.3.Goats
- 8.1.4.People
- 8.1.5.Sheep
- 8.1.6.Other

9.Rift Valley Fever Vaccines Market- By Geography

9.1.Introduction
- 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2.North America
- 9.2.1.Overview
- 9.2.2.Rift Valley Fever Vaccines Key Manufacturers in North America
- 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.6.U.S.
  - 9.2.6.1.Overview
  - 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.7.Canada
  - 9.2.7.1.Overview
  - 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.Europe
- 9.3.1.Overview
- 9.3.2.Rift Valley Fever Vaccines Key Manufacturers in Europe
- 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.6.Germany
  - 9.3.6.1.Overview
  - 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.7.Italy
  - 9.3.7.1.Overview
  - 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.8.United Kingdom
  - 9.3.8.1.Overview
  - 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.9.France
  - 9.3.9.1.Overview
  - 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.10.Russia
  - 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.11.Netherlands
  - 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.12.Sweden
  - 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.13.Poland
  - 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.14.Rest of Europe
  - 9.3.14.1.Overview
  - 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.Asia Pacific (APAC)
- 9.4.1.Overview
- 9.4.2.Rift Valley Fever Vaccines Key Manufacturers in Asia Pacific
- 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.6.India
  - 9.4.6.1.Overview
  - 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.7.China
  - 9.4.7.1.Overview
  - 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.8.Japan
  - 9.4.8.1.Overview
  - 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.9.South Korea
  - 9.4.9.1.Overview
  - 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.10.Australia
  - 9.4.10.1.Overview
  - 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.11.Thailand
  - 9.4.11.1.Overview
  - 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.12.Indonesia
  - 9.4.12.1.Overview
  - 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.13.Philippines
  - 9.4.13.1.Overview
  - 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.14.Rest of APAC
  - 9.4.14.1.Overview
  - 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.Latin America
- 9.5.1.Overview
- 9.5.2.Rift Valley Fever Vaccines Key Manufacturers in Latin America
- 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.6.Brazil
  - 9.5.6.1.Overview
  - 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.7.Mexico
  - 9.5.7.1.Overview
  - 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.8.Argentina
  - 9.5.8.1.Overview
  - 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.9.Colombia
  - 9.5.9.1.Overview
  - 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.10.Rest of LATAM
  - 9.5.10.1.Overview
  - 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.Middle East and Africa
- 9.6.1.Overview
- 9.6.2.Rift Valley Fever Vaccines Key Manufacturers in Middle East and Africa
- 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.6.Saudi Arabia
  - 9.6.6.1.Overview
  - 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.7.United Arab Emirates
  - 9.6.7.1.Overview
  - 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.8.Israel
  - 9.6.8.1.Overview
  - 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.9.Turkey
  - 9.6.9.1.Overview
  - 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.10.Algeria
  - 9.6.10.1.Overview
  - 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.11.Egypt
  - 9.6.11.1.Overview
  - 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.12.Rest of MEA
  - 9.6.12.1.Overview
  - 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Rift Valley Fever Vaccines Industry

10.1.Competitive Dashboard
10.2.Company Profiles
- 10.2.1.Veterinary Serum and Vaccine Research Institute
- 10.2.2.Medgene Labs
- 10.2.3.VSVRI
- 10.2.4.Onderstepoort Biological Products
- 10.2.5.OBP
- 10.2.6.Others

11.360 Degree Analyst View

12.Appendix

12.1.Research Methodology
12.2.References
12.3.Abbreviations
12.4.Disclaimer
12.5.Contact Us